SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The companyâ€™s polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
Funding Rounds (4) - $5.2MUpdate
Providence based angel group interested in biopharma, medical device and tech startups in New...
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of...
CommonAngels is a hybrid venture capital investing in technology-based seed and early-stage...
100 Cummings Center
Beverly, MA 01915